Literature DB >> 15479723

Meis1-mediated apoptosis is caspase dependent and can be suppressed by coexpression of HoxA9 in murine and human cell lines.

Peter J Wermuth1, Arthur M Buchberg.   

Abstract

Coexpression of the homeodomain protein Meis1 and either HoxA7 or HoxA9 is characteristic of many acute myelogenous leukemias. Although Meis1 can be overexpressed in bone marrow long-term repopulating cells, it is incapable of mediating their transformation. Although overexpressing HoxA9 alone transforms murine bone marrow cells, concurrent Meis1 overexpression greatly accelerates oncogenesis. Meis1-HoxA9 cooperation suppresses several myeloid differentiation pathways. We now report that Meis1 overexpression strongly induces apoptosis in a variety of cell types in vitro through a caspase-dependent process. Meis1 requires a functional homeodomain and Pbx-interaction motif to induce apoptosis. Coexpressing HoxA9 with Meis1 suppresses this apoptosis and provides protection from several apoptosis inducers. Pbx1, another Meis1 cofactor, also induces apoptosis; however, coexpressing HoxA9 is incapable of rescuing Pbx-mediated apoptosis. This resistance to apoptotic stimuli, coupled with the previously reported ability to suppress multiple myeloid differentiation pathways, would provide a strong selective advantage to Meis1-HoxA9 coexpressing cells in vivo, leading to leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15479723     DOI: 10.1182/blood-2004-03-0802

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Role of MAML1 and MEIS1 in Esophageal Squamous Cell Carcinoma Depth of Invasion.

Authors:  Mohammad Reza Abbaszadegan; Meysam Moghbeli
Journal:  Pathol Oncol Res       Date:  2017-05-01       Impact factor: 3.201

2.  HOXA9 is required for survival in human MLL-rearranged acute leukemias.

Authors:  Joerg Faber; Andrei V Krivtsov; Matthew C Stubbs; Renee Wright; Tina N Davis; Marry van den Heuvel-Eibrink; Christian M Zwaan; Andrew L Kung; Scott A Armstrong
Journal:  Blood       Date:  2008-12-03       Impact factor: 22.113

3.  HOX proteins and leukemia.

Authors:  Kajal V Sitwala; Monisha N Dandekar; Jay L Hess
Journal:  Int J Clin Exp Pathol       Date:  2008-03-30

4.  MEIS1, PREP1, and PBX4 are differentially expressed in acute lymphoblastic leukemia: association of MEIS1 expression with higher proliferation and chemotherapy resistance.

Authors:  Judith A Rosales-Aviña; Jorge Torres-Flores; Adriana Aguilar-Lemarroy; Carmen Gurrola-Díaz; Georgina Hernández-Flores; Pablo C Ortiz-Lazareno; José M Lerma-Díaz; Ruth de Celis; Óscar González-Ramella; Esperanza Barrera-Chaires; Alejandro Bravo-Cuellar; Luis F Jave-Suárez
Journal:  J Exp Clin Cancer Res       Date:  2011-12-20

Review 5.  PBX1: a key character of the hallmarks of cancer.

Authors:  Rafaela Nasser Veiga; Jaqueline Carvalho de Oliveira; Daniela Fiori Gradia
Journal:  J Mol Med (Berl)       Date:  2021-09-16       Impact factor: 4.599

6.  RE-IIBP Methylates H3K79 and Induces MEIS1-mediated Apoptosis via H2BK120 Ubiquitination by RNF20.

Authors:  Jin Woo Park; Kee-Beom Kim; Ji-Young Kim; Yun-Cheol Chae; Oh-Seok Jeong; Sang-Beom Seo
Journal:  Sci Rep       Date:  2015-07-24       Impact factor: 4.379

7.  HOXA9 inhibits HIF-1α-mediated glycolysis through interacting with CRIP2 to repress cutaneous squamous cell carcinoma development.

Authors:  Liang Zhou; Yinghui Wang; Meijuan Zhou; Ying Zhang; Pengfei Wang; Xiaoxing Li; Jing Yang; Hongmei Wang; Zhenhua Ding
Journal:  Nat Commun       Date:  2018-04-16       Impact factor: 14.919

8.  CBAP modulates Akt-dependent TSC2 phosphorylation to promote Rheb-mTORC1 signaling and growth of T-cell acute lymphoblastic leukemia.

Authors:  Yun-Jung Chiang; Wei-Ting Liao; Kun-Chin Ho; Shih-Hao Wang; Yu-Guang Chen; Ching-Liang Ho; Shiu-Feng Huang; Lee-Yung Shih; Hsin-Fang Yang-Yen; Jeffrey Jong-Young Yen
Journal:  Oncogene       Date:  2018-09-28       Impact factor: 9.867

9.  Oncogenic and tumor suppressor function of MEIS and associated factors.

Authors:  Birkan Gİrgİn; Medine KaradaĞ-Alpaslan; Fatih KocabaŞ
Journal:  Turk J Biol       Date:  2020-12-14

Review 10.  MEIS1 and its potential as a cancer therapeutic target (Review).

Authors:  Maozhong Yao; Yong Gu; Zhaoxin Yang; Keyan Zhong; Zhanjuan Chen
Journal:  Int J Mol Med       Date:  2021-07-28       Impact factor: 4.101

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.